Therapeutics

BRUCELLA GREEN VAC

Kaori Mutsuda Zapater, 21 September, 2021, 0

BRUCELLA GREEN VAC S.L. We develop a new generation of brucella vaccines, being BGV1 our 1st product, addressed to sheep...

+

Kintsugi Therapeutics

Kaori Mutsuda Zapater, 1 September, 2021, 0

Kintsugi Therapeutics Kintsugi Therapeutics is a preclinical-stage biotechcompany developing a first-in-class treatment for NASH. Biotech Prototyping, preclinical Spain 1.000.000€...

+

AntalGenics

Kaori Mutsuda Zapater, 7 July, 2021, 0

AntalGenics, S.L. Innovative Sensory Neurobiology Biotech Prototyping, preclinical Spain 800.000€ Status Approved IP Type Patent Time 16 years Countries Australia...

+

Gencyte Therapeutics, Inc.

Marc Sastre Capital Cell, 10 March, 2021, 0

Gencyte Therapeutics, Inc. Developing next generation of CAR-T platform for cancer treatment. Therapeutics Discovery, Idea USA 1.000.000€ IP Type Status...

+

UTCCB

Marc Sastre Capital Cell, 14 May, 2020, 0

UTCCB First center in Spain specialized in situations related to emotional and stress disorders Therapeutics Sales, licensing phases España 65.400€...

+

PlusVitech

Marc Sastre Capital Cell, 12 May, 2020, 0

PlusVitech Effective treatment by reprofiling an existing drug to save lives from COVID-19 lung damage Therapeutics Development, market readiness, clinical...

+

aptaTargets

Marc Sastre Capital Cell, 12 May, 2020, 0

aptaTargets aptaTargets innovates through aptamer technology Therapeutics Development, market readiness, clinical trial Spain 1.930.000€ You can visit their website or...

+

Glycon Pharma

Marc Sastre Capital Cell, 4 February, 2020, 0

Glycon Pharma Dopamine glycoconjugate that traverses the blood-brain barrier. And more... Therapeutics Prototyping, preclinical USA 1.500.000$ You can visit their...

+

Limnopharma

Pilar Puig, 12 September, 2019, 0

Limnopharma Novel treatments for disabling ophthalmic diseases Therapeutics In vitro, proof of concept Spain 500.000€ You can visit their website...

+

Navega Therapeutics

John Bethell, 9 May, 2019, BEN Only, Requested Initial Meeting, Undergoing Evaluation, 0

Navega Therapeutics Next generation pain management Therapeutics Prototyping, preclinical USA 500.000€ You can visit their website or Under evaluation at...